Presidio property trust announces closing of merger of its sponsored spac murphy canyon acquisition corp now trading as conduit pharmaceuticals (nasdaq: cdt and cdttw)

Presidio's sponsored spac completed its previously announced business combination with conduit pharmaceuticals, inc. conduit now trades on the nasdaq under ticker symbol “cdt” for its common stock on the global market and ticker symbol “cdttw” for its warrants on the capital market san diego, oct. 06, 2023 (globe newswire) -- presidio property trust, inc., (nasdaq: sqft; sqftp; sqftw) (“presidio” or the “company”), today announced the successful merger with and commencement of trading of conduit pharmaceuticals, inc., now trading on nasdaq under the ticker symbol cdt for common stock on the global market and ticker symbol cdttw for warrants on the capital market. in connection with the completion of the merger, presidio's sponsored spac murphy canyon acquisition corp. changed its name to conduit pharmaceuticals inc. conduit is a disease agnostic multi-asset clinical-stage disease-agnostic life science company providing an efficient model for compound development.
SQFT Ratings Summary
SQFT Quant Ranking